(Q62559186)
Statements
A 12-month phase 3 study of pasireotide in Cushing's disease (English)
Annamaria Colao
Stephan Petersenn
John Newell-Price
Feng Gu
Mario Maldonado
Ulrike Schoenherr
James W Findling
David Mills
Luiz Roberto Salgado
Beverly M K Biller
Pasireotide B2305 Study Group